New York under the Rivers decision: an epidemiologic study of drug treatment refusal.
OBJECTIVE
To determine the characteristics of cases of drug treatment refusal under the Rivers decision, which mandated court adjudication of such cases, the authors made a retrospective study of all applications for court review during 1 year in New York State inpatient facilities.


METHODS
Sociodemographic and clinical characteristics of these 473 cases were compared with those of the 41,535 cases during the same period in which no court review was requested.


RESULTS
A 1% prevalence of applications requesting court review for nonemergency administration of medication over objection was found. The patients who refused medication were more likely than the comparison patients to have a crime-associated commitment status, a diagnosis of schizophrenia, and fewer previous hospital days, and they were more likely to be discharged. Medication refusers for whom applications for court review were submitted had relatively longer hospitalizations than the rest of the patients. Almost one-third of the applications submitted were withdrawn before court hearings, yielding a 0.7% prevalence of court-reviewed applications. Ninety-two percent of these applications for medication over objection were approved with virtually no change in the requested orders.


CONCLUSIONS
The study findings demonstrate that a front-end judicial determination of competency to refuse medication results in a time-consuming procedure which fails to ensure real due process or provide individualized alternative treatment. A two-tier system with in-house clinical review preceding judicial review is proposed to remedy the deficiencies of the current system.
Zito
J M
JM
Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962.
Craig
T J
TJ
Wanderling
J
J
D003134:Commitment of Persons with Psychiatric Disorders; D005555:Forensic Psychiatry / Q000331:legislation & jurisprudence; D006801:Humans; D033222:Judicial Role; D001523:Mental Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D028642:Persons with Psychiatric Disorders; D009518:New York; D011619:Psychotropic Drugs / Q000627:therapeutic use; D016312:Treatment Refusal
D011619:Psychotropic Drugs